Cargando…
Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...
Autores principales: | Ji, Lixia, Cheng, Lixia, Yang, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605930/ https://www.ncbi.nlm.nih.gov/pubmed/29038789 http://dx.doi.org/10.1155/2017/7309816 |
Ejemplares similares
-
Upregulations of Clcn3 and P-Gp Provoked by Lens Osmotic Expansion in Rat Galactosemic Cataract
por: Ji, Lixia, et al.
Publicado: (2017) -
Search of inhibitors of aldose reductase for treatment of diabetic cataracts using machine learning
por: Chen, Trevor, et al.
Publicado: (2023) -
In Search of Differential Inhibitors of Aldose Reductase
por: Balestri, Francesco, et al.
Publicado: (2022) -
Aldose reductase and glutathione in senile cataract nucleus of diabetics and non-diabetics
por: Khare, Kanishk, et al.
Publicado: (2023) -
General toxicity assessment of the novel aldose reductase inhibitor cemtirestat
por: PRNOVÁ, Marta ŠOLTÉSOVÁ, et al.
Publicado: (2019)